Cargando…

NASH-related increases in plasma bile acid levels depend on insulin resistance

BACKGROUND & AIMS: Plasma bile acids (BAs) have been extensively studied as pathophysiological actors in non-alcoholic steatohepatitis (NASH). However, results from clinical studies are often complicated by the association of NASH with type 2 diabetes (T2D), obesity, and insulin resistance (IR)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Grzych, Guillaume, Chávez-Talavera, Oscar, Descat, Amandine, Thuillier, Dorothée, Verrijken, An, Kouach, Mostafa, Legry, Vanessa, Verkindt, Hélène, Raverdy, Violeta, Legendre, Benjamin, Caiazzo, Robert, Van Gaal, Luc, Goossens, Jean-Francois, Paumelle, Réjane, Francque, Sven, Pattou, François, Haas, Joel T., Tailleux, Anne, Staels, Bart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878982/ https://www.ncbi.nlm.nih.gov/pubmed/33615207 http://dx.doi.org/10.1016/j.jhepr.2020.100222

Ejemplares similares

Hepatic Molecular Signatures Highlight the Sexual Dimorphism of Nonalcoholic Steatohepatitis (NASH)
por: Vandel, Jimmy, et al.
Publicado: (2020)

Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients
por: Margerie, Daniel, et al.
Publicado: (2019)

Letter to the editor: Regression of liver fibrosis after bariatric operations: A glass two‐third full rather than half empty
por: Pattou, François, et al.
Publicado: (2022)

Apolipoprotein F is reduced in humans with steatosis and controls plasma triglyceride‐rich lipoprotein metabolism
por: Deprince, Audrey, et al.
Publicado: (2023)

Post-Bariatric Surgery Changes in Quinolinic and Xanthurenic Acid Concentrations Are Associated with Glucose Homeostasis
por: Favennec, Marie, et al.
Publicado: (2016)

Peroxisomal β-oxidation acts as a sensor for intracellular fatty acids and regulates lipolysis
por: Ding, Lianggong, et al.
Publicado: (2021)

Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features
por: Vonghia, Luisa, et al.
Publicado: (2015)

Review article: vascular effects of PPARs in the context of NASH
por: Guixé‐Muntet, Sergi, et al.
Publicado: (2022)

The tumour suppressor CDKN2A/p16(INK4a) regulates adipogenesis and bone marrow-dependent development of perivascular adipose tissue
por: Wouters, Kristiaan, et al.
Publicado: (2017)

Performance of Biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in Patients with Severe Obesity: Meta Analysis of Individual Patient Data
por: Poynard, Thierry, et al.
Publicado: (2012)

Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH
por: L’homme, Laurent, et al.
Publicado: (2020)

Bone Marrow p16(INK4a)-Deficiency Does Not Modulate Obesity, Glucose Homeostasis or Atherosclerosis Development
por: Wouters, Kristiaan, et al.
Publicado: (2012)

Pathophysiology of NASH in endocrine diseases
por: Gariani, Karim, et al.
Publicado: (2021)

Erratum. Ten-Year Outcome of Islet Alone or Islet After Kidney Transplantation in Type 1 Diabetes: A Prospective Parallel-Arm Cohort Study. Diabetes Care 2019;42:2042–2049
por: Vantyghem, Marie-Christine, et al.
Publicado: (2020)

An Evaluation of the Implementation of the European Calcified Tissue Society Recommendations on the Prevention and Treatment of Osteoporosis Secondary to Bariatric Surgery
por: Courtalin, Marion, et al.
Publicado: (2023)

Functional genomics uncovers the transcription factor BNC2 as required for myofibroblastic activation in fibrosis
por: Bobowski-Gerard, Marie, et al.
Publicado: (2022)

Surveillance for Hepatocellular Carcinoma in Patients with NASH
por: Kolly, Philippe, et al.
Publicado: (2016)

Primary Graft Function, Metabolic Control, and Graft Survival After Islet Transplantation
por: Vantyghem, Marie-Christine, et al.
Publicado: (2009)

Preclinical Assessment of Leptin Transport into the Cerebrospinal Fluid in Diet‐Induced Obese Minipigs
por: Chmielewski, Alexandra, et al.
Publicado: (2019)

Relationship between salivary/pancreatic amylase and body mass index: a systems biology approach
por: Bonnefond, Amélie, et al.
Publicado: (2017)

Non-Alcoholic Steatohepatitis Decreases Microsomal Liver Function in the Absence of Fibrosis
por: Verlinden, Wim, et al.
Publicado: (2020)

Best Poster Award – Second Prize: Bile Acids as Novel Vascular Signalling Molecules and Therapeutic Target
por: Jomard, A, et al.
Publicado: (2020)

Current therapies and new developments in NASH
por: Dufour, Jean-François, et al.
Publicado: (2022)

Multiple Selection Criteria for Probiotic Strains with High Potential for Obesity Management
por: Alard, Jeanne, et al.
Publicado: (2021)

Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD
por: du Plessis, Johannie, et al.
Publicado: (2016)

Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022)

Impaired Expression of the Inducible cAMP Early Repressor Accounts for Sustained Adipose CREB Activity in Obesity
por: Favre, Dimitri, et al.
Publicado: (2011)

Impaired histone deacetylases 5 and 6 expression mimics the effects of obesity and hypoxia on adipocyte function
por: Bricambert, Julien, et al.
Publicado: (2016)

Nash vek /
por: Nappelʹbaum, Moisei Solomonovich, 1869-1958
Publicado: (1984)

Nash manifolds
por: Shiota, Masahiro
Publicado: (1987)

Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?
por: Baron, Morgane, et al.
Publicado: (2012)

Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
por: Hirsova, Petra
Publicado: (2021)

Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis
por: Hayashi, Momoko, et al.
Publicado: (2023)

A targeted multi-omics approach reveals paraoxonase-1 as a determinant of obesity-associated fatty liver disease
por: Diels, Sara, et al.
Publicado: (2021)

The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity
por: Bricambert, Julien, et al.
Publicado: (2018)

A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression
por: Blasco, Hélène, et al.
Publicado: (2018)

Diet-induced obesity and NASH aggravate SARS-CoV-2 infection in golden Syrian hamsters
por: Briand, François, et al.
Publicado: (2022)

From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
por: Gastaldelli, Amalia, et al.
Publicado: (2019)

Endoplasmic Reticulum and Mitochondria Contacts Correlate with the Presence and Severity of NASH in Humans
por: Jin, Chaonan, et al.
Publicado: (2022)

The essential John Nash
por: Nash, John, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_2pavnd6ja5bnl83746u834c8lh